Biotech · Private company
Tocagen Inc.
Track this companyFree. Adds Tocagen Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs9From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline9
- BevacizumabPhase 3 · Glioblastoma MultiformeClinicalTrials.gov · fetched Nov 12, 2026
- LomustinePhase 3 · Glioblastoma MultiformeClinicalTrials.gov · fetched Nov 12, 2026
- TemozolomidePhase 3 · Glioblastoma MultiformeClinicalTrials.gov · fetched Nov 12, 2026
- Toca 511Phase 3 · Glioblastoma MultiformeClinicalTrials.gov · fetched Nov 12, 2026
- Toca FCPhase 3 · Glioblastoma MultiformeClinicalTrials.gov · fetched Nov 12, 2026
- Toca 511Phase 1 · Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- Toca 511 vectorPhase 1 · Glioblastoma MultiformeClinicalTrials.gov · fetched Nov 12, 2026
- Toca FCPhase 1 · Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- Toca FC • Flucytosine • 5-FC • 5-FluorocytosinePhase 1 · Glioblastoma MultiformeClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma (Toca 6)PHASE1 · TERMINATED · started Jul 1, 2016ClinicalTrials.gov NCT02576665 · fetched Nov 12, 2026
- The Toca 5 Trial: Toca 511 & Toca FC Versus Standard of Care in Patients With Recurrent High Grade GliomaPHASE2_PHASE3 · TERMINATED · started Nov 30, 2015ClinicalTrials.gov NCT02414165 · fetched Nov 12, 2026
- A Continuation Protocol for Patients Previously Enrolled in a Study of Toca 511PHASE1 · TERMINATED · started Feb 1, 2011ClinicalTrials.gov NCT04327011 · fetched Nov 12, 2026